Evidence map›Paper›PMID 31391695›Full record

ArticleMedical archives (Sarajevo, Bosnia and Herzegovina)2019

Comparison of Serum Ykl-40 and Ischemia Modified Albulmin Levels Between Pregnant Women with Hyperemesis Gravidarum and Normal Pregnant Women.

Murat Bulanık, Nevin Sağsöz, Cemile Dayangan Sayan, Mahmut İlkin Yeral, Üçler Kısa

Abstract read
In one paragraph

Article in Medical archives (Sarajevo, Bosnia and Herzegovina), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Murat BulanıkDepartment of Obstetrics and Gynecology, Zonguldak Devrek State Hospital, Turkey.
Nevin SağsözDepartment of Obstetrics and Gynecology, Kırıkkale University Faculty of Medicine, Kırıkkale, Turkey.
Cemile Dayangan SayanDepartment of Obstetrics and Gynecology, Kırıkkale University Faculty of Medicine, Kırıkkale, Turkey.
Mahmut İlkin YeralDepartment of Obstetrics and Gynecology, Kırıkkale University Faculty of Medicine, Kırıkkale, Turkey.
Üçler KısaDepartment of Biochemistry, Kırıkkale University Faculty of Medicine, Kırıkkale, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe etiopathogenesis of HG is still unclear.

aimThe aim of this study was to investigate the levels of YKL-40 protein as an inflammatory marker and evaluate the levels of IMA as an oxidative marker in hyperemesis gravidarum women. MATERIALS AND

methodsTotally 35 patients with hyperemesis gravidarum and 35 healthy pregnants were included in the study. Singleton pregnancies between 6+0 week and 13+6 weeks of gestation, with normal fetal anatomy were included in the study. Complete blood count, complete urine analyze, biochemical tests and thyroid function tests were done.

resultsThere was no significant difference between groups for demographical features (age, gravidity, gestational age, body mass index). Also, there was no statistically significant difference between groups for IMA levels (p>0.05). The median level of YKL-40 was higher in pregnants with hyperemesis gravidarum than normal pregnants but the difference was not statistically significance (p>0.05).

conclusionFurther comprehensive studies with more number of patients are needed to show the efficacy of YKL-40 and IMA levels for predicting hyperemesis gravidarum and even monitoring of the treatment.

Indexed as

AdultBiomarkersCase-Control StudiesChitinase-3-Like Protein 1FemaleHumansHyperemesis GravidarumInflammationOxidative StressPregnancyPregnancy Trimester, FirstPregnancy Trimester, SecondSerum Albumin, HumanYoung AdultBiomarkersCHI3L1 protein, humanChitinase-3-Like Protein 1ischemia-modified albuminSerum Albumin, HumanHyperemesis gravidaruminflammationIschemia modified albuminoxidative stressYKL-40

Identifiers

PMID31391695
PMCPMC6643323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.